MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 238 filers reported holding MYRIAD GENETICS INC in Q1 2017. The put-call ratio across all filers is 2.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,616,000 | -60.4% | 55,600 | -37.3% | 0.11% | -52.6% |
| Q3 2018 | $4,080,000 | +68.2% | 88,700 | +36.7% | 0.23% | +64.8% |
| Q2 2018 | $2,425,000 | -62.4% | 64,900 | -63.6% | 0.14% | -58.8% |
| Q3 2017 | $6,443,000 | -2.5% | 178,100 | -30.3% | 0.34% | -15.4% |
| Q2 2017 | $6,607,000 | +16.2% | 255,700 | -13.6% | 0.41% | +13.6% |
| Q1 2017 | $5,685,000 | +15.2% | 296,100 | 0.0% | 0.36% | -11.6% |
| Q4 2016 | $4,935,000 | -5.9% | 296,100 | +16.2% | 0.41% | -4.5% |
| Q3 2016 | $5,243,000 | +1025.1% | 254,800 | +2005.8% | 0.42% | +507.1% |
| Q3 2014 | $466,000 | – | 12,100 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |